Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melanoma vaccines.

M F Naylor1

  • 1Department of Dermatology, University of Oklahoma Health Sciences Center, USA.

Dermatology Online Journal
|May 1, 2001
PubMed
Summary

Melanoma vaccines offer a promising near-term strategy to reduce mortality in advanced melanoma. Their low toxicity also makes them suitable for adjuvant therapy in high-risk early-stage melanoma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In situ photoimmunotherapy: a tumour-directed treatment for melanoma.

The British journal of dermatology·2006
Same author

American Academy of Dermatology--59th annual meeting.

IDrugs : the investigational drugs journal·2005
Same author

Treatment of lentigo maligna with topical imiquimod.

The British journal of dermatology·2003
Same author

Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.

Archives of dermatology·2001
Same author

Noninvasive methods of diagnosing thoracic splenosis.

The Annals of thoracic surgery·1999
Same author

9p21 deletions in primary melanoma.

Dermatology online journal·1998

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Advanced melanoma presents a significant mortality challenge.
  • Current treatment options for advanced melanoma have limitations.
  • Melanoma vaccines are emerging as a novel therapeutic approach.

Purpose of the Study:

  • To review recent advancements in melanoma vaccine development.
  • To emphasize the significance of these vaccines for dermatologists.
  • To explore the potential of melanoma vaccines in both advanced and adjuvant settings.

Main Methods:

  • Review of recent scientific literature on melanoma vaccines.
  • Analysis of vaccine efficacy and toxicity data.
  • Discussion of clinical trial outcomes and ongoing research.

Main Results:

  • Melanoma vaccines show potential in improving survival rates for advanced disease.
  • Low toxicity profiles make vaccines suitable for adjuvant therapy.
  • Ongoing research is expanding the application of melanoma vaccines.

Conclusions:

  • Melanoma vaccines represent a key development in oncology.
  • These vaccines hold promise for improving patient outcomes in melanoma.
  • Dermatologists should be aware of the evolving role of melanoma vaccines.

Related Experiment Videos